acasti pharma stock price target

The Wall Street analyst predicted. ACST stock has declined by more than 50 year to date YTD vastly.

Acasti Pharma Nasdaq Acst Quotes And News Summary Benzinga

Their forecasts range from 600 to 600.

. Do note that if the stock price. The latest price target for Acasti Pharma NASDAQ. The company is now focused on the development of medicines for rare conditions and each of its candidates may offer meaningful advantages over standard-of-care while mitigating development risk and cost Gershell tells investors in a research note.

According to the issued ratings of 1 analysts in the last year the consensus rating for Acasti Pharma stock is Buy based on the current 1 buy rating for ACST. 14 2020 at 856 am. Price Target Last Issued February 15 2022 ACST reports an average of -1962 for its upside potential over the past 45 weeks.

Shares of Acasti Pharma NASDAQ. The stock price of Acasti Pharma Inc NASDAQ. Acasti Pharma Inc Change.

The average ACASTI PHARMA stock price prediction forecasts a potential upside of 38387 from the current ACST share price of 124. The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 500 with a high estimate of 500 and a low estimate of 500. With a pricesales ratio of 46599 Acasti Pharma Inc has a higher such ratio than 9912 of stocks in our set.

Given the current short-term trend the stock is expected to fall -861 during the next 3 months and with a 90 probability hold a price between 083 and 117 at the end of this 3-month period. - Exotistan Stock CAD 283 002 070 Analysts of ACASTI PHARMA INC render investment recommendations by dissecting financials analyzing earning calls and talking to ACASTI PHARMA vendors executives and customers to validate their buy-or-sell advice. Oppenheimer Adjusts Acasti Pharmas Price Target to 5 From 6 Maintains Outperform Ra.

ET by Tomi Kilgore. Jun 20 2022 - Jun 24 2022. Shares of Acasti Pharma stock traded up 004 during trading on Tuesday hitting 118.

The analyst firm set a price target for 600 expecting ACST to rise to within 12 months. ET by Tomi Kilgore Acasti Pharma downgraded to neutral from buy at B. On average they anticipate Acasti Pharmas stock price to reach 600 in the next twelve months.

14 2020 at 856 am. They set an outperform rating and a 600 price target on the stock. Oppenheimer analyst Leland Gershell initiated coverage of Acasti Pharma with an Outperform rating and 6 price target.

Fair Value is the appropriate price for the shares of a company based on its earnings. The stock had a trading volume of 2508 shares compared to its average volume of 336665. The current price of Acasti Pharma is the price at which Acasti Pharma is currently trading.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Acasti Pharma stock price target cut to 2 from 8 at B. ACST are jumping more than 25 higher today after a major investment firm initiated coverage.

Acasti Pharma Inc ACST Price Targets From Analysts Use the tables below to see what analysts covering Acasti Pharma Inc think about its future price and what recommendations they have for investors and traders. Acasti Pharma stock price target cut to 2 from 8 at B. Acasti Pharma Target Price Projection Acasti Pharmas current and average target prices are 121 and 600 respectively.

NA NA Ex-Dividend Date. 093 Microsoft strongly encourages users to switch to a different browser than. This suggests a possible upside of 4172 from the stocks current price.

That ACASTI PHARMAs share price could reach 600 by Dec 22 2022. View analysts price targets for Acasti Pharma or view top-rated stocks among Wall Street analysts. Quarterly Annual Actual Analyst Range Consensus 010 000 -010 -020 ACST will report.

Forward Dividend Yield. The median estimate represents a. ACST Stock Trend.

Learn more on ACSTs analyst rating history. ACST a biopharmaceutical company that has historically focused on the research development and commercialization of prescription drugs using OM3 fatty acids delivered both as free fatty acids and bound-to-phospholipid esters derived from krill oil is trading at over 12 pre-market as of 633 AM ET. The more significant the discrepancy between the two.

On the other hand Acasti Pharmas target price is what analysts think the stock is worth or could sell for in the future. With a year-over-year growth in debt of -7905 Acasti Pharma Incs debt growth rate surpasses only 324 of about US stocks. Acasti Pharma has.

The average twelve-month price target for Acasti Pharma is 600 with a high price target of 600 and a low price target of 600. In depth view into Acasti Pharma Price Target Upside Daily including historical data from 2011 charts stats and industry comps. Per-Share Earnings Actuals Estimates Acasti Pharma Inc.

ACST was reported by Oppenheimer on December 22 2021.

Market Sentiment Around Loss Making Acasti Pharma Inc Cve Acst